Trading Summary - March 10. A more than satisfactory

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
179
Trading Summary - March 10.

A more than satisfactory status quo day for $SFLM today - all trades continued to be within the 25% percentile under .0050 of the .02+ anticipated in 2022.

This was despite many OTC market top traders wanting to prioritize the first hour of their day on the gap up and early run on $ENZC on news and again - for the third day in a row - a lot of the funds getting sucked out of the OTC markets by people wasting 172M in buying power on the inferior jewelry company $BRGO with it still going down in the .0012 > .0014 range.

The basher / scammer on iHub had already stated yesterday that he would be trying to sell his .0008s in the days ahead.

Traders willing to take his shares jockeyed for position all day with an increased bid up to 17M at .0010 (of which no significant amount filled), moving up to 12M of the bid up to .0011 and taking out any undercut asks at .0012 and more of the .0013s.

Notables buys on the ask at .0012 were 4M+ and 3M+.

Expect top traders of $SFLM to take out ever decreasing asks on the way to .01+ and also outbid the repeat scamming basher / flippers until they get to the stage where they have no .0008> .0010s left and can't reload.

At the next share structure update due anytime now, we will know if there were any other $50K / 62.5M Public Offering bulk purchases or not - and even if there were, even several would not be a problem as many 100Ms have been traded since the last increase on February 9 (which I will add up and comment on in future DD updates).

We can expect asks in the .0015 to .0020 range to get back to the more normal 5M > 500K and then more usually 1M > 200K after that all the way to .01+.

Overall, 36.5M shares were traded today - almost all .0011 > .00013.

None of the asks are of any significance to hinder a quick break above .0020 towards the .01 > .02 range needed for OTCQB uplisting - and as appropriate to its $13M+ revenue estimate currently (even before diversification of revenue streams).

We still need to see significant buys across several asks at the open that are crucial to getting the breakout to the .01 > .02+ range started.

The facts about the Public Offering and the Share Structure are as follows (as already in the master DD updated weekly):

- 2 Billion shares have not been issued - 2 Billion shares have been offered for purchase in initial blocks of $50K / 62.5M or follow on blocks of $10K / 12.5M - as stated in the DD.

As at the latest update dated February 9, only 3 x such purchases could have been made as the increase was precisely 187.5M - also in the DD.

- The previous Public Offering of 2.2 Billion only had 352.5M bought throughout 2021 and all that was most probably traded on the runs to .02.

- The last reverse split of the predecesor company $SKDI was on June 3, 2019 and is irrelevant.

- The CEO has already stated that there is no reason for a reverse split - and there clearly isn't any need for one [source: PR October 9, 2020].

- The A/S is 5B and the Total O/S is only 1.640B.

Authorized Shares: 5,000,000,000 [same as in January 2020]

Outstanding Shares: 1,640,525,173 [no change October 9 > January 20 - up 187.5M January 21 > February 9]

Restricted: 615,504,231 [no change September 9 > February 9]

Unrestricted: 1,025.020,942 [up 321.25M in 11 months September 2020 > August 2021 - up 50M August 2 > September 8 from formerly Restricted - up 43.75M September 8 > October 8 - no change October 9 > January 20 - up 187.5M January 21 > February 9]

The correct market cap price for the anticipated revenue as income ramps up under the Collectibles Marketplace Strategy is currently .0815 (see DD for calculation).

Remember that the price difference between .0015 and .0050 is irrelevant when traded at .01 > .02+ - let alone at .0815 - apart from the additional partial profits taken on the way to the long-term target.

Every 1M bought at .0010 is worth $11K profit at .0120.

Every 1M bought at .0020 is worth a $10K profit at .0120 or $18K profit at .02.

Latest DD - updated March 6 - here:

https://investorshangout.com/post/view?id=6356929

$SFLM was the #1 Top Profit Pick and #1 Top Banked Profit stock of 2021 on my Watch List.

It is also my #1 Top Profit Pick for the whole of 2022.

Major catalysts ahead in 2022 are:

- Continued excellent revenue growth from the core Jewelry Division.

- Updates on the Metaverse Division.

- Updates on the NFT Division.

- Acquisitions of other collectibles companies - some already in discussions.

- 2021 Q4 / Annual Report filing.

- OTCQB uplisting.

13th CEO Video here:

https://vimeo.com/673267050

14th CEO Video here:

https://vimeo.com/675954496

Watch out for the next PR which we can expect to be on the setting up of the Metaverse "store".

There are now only a maximum of only 13 trading days before the record revenue 2021 Annual Report is filed.

Advance sales this week from March 4 at "Buy It Now" prices are now a record $61,056 - including an item for $35,000 - the highest price achieved since the company went public - possibly ever.

https://www.ebay.com/itm/234451164461?hash=it...SwqwdiImOC

Next auction closes tonight - bids already are $196,625:

https://www.ebay.com/sch/i.html?_dmd=2&ic...amp;_pgn=1

So the revenue for Week 10 will be at least $257,681 - and will probably be in the $275K > $320K+ range again.

Watch out for an update from me after the auction closes.

https://www.ebay.com/sch/i.html?_dmd=2&ic...amp;_pgn=1

SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 261

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 305

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 210

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 156

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 460

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 272

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 278

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 220

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 256

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 213

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading

Top 5 Most Recently Viewed Articles

Clene Inc. Set to Showcase Innovations at Key Conference

Updated Category News Views 149

Clene Inc. Ready for Emerging Growth Conference Presentation Clene Inc. (NASDAQ: CLNN), a pioneering clinical-stage biopharmaceutical company, is set to present at the Emerging Growth Conference. This upcoming event marks a significant opportunity for Clene to showcase its groundbreaking approach in the realm of mitochondrial health and neuroprotection, particularly with...

Continue Reading
Corbion Launches €10 Million Share Buyback Initiative for Employees

Updated Category News Views 223

Corbion Introduces a New Share Buyback Program Corbion N.V. is thrilled to announce its latest initiative, a share buyback program, set to repurchase ordinary shares for a total maximum value of €10 million and up to 580,383 shares. This strategic move underscores the company's commitment to supporting its employees while reinforcing its economic stability. Program...

Continue Reading
SPRY Therapeutics Celebrates Recognition with G2 Fall 2024 Badges

Updated Category News Views 251

SPRY Therapeutics achieved a significant milestone back in Fall 2024, snagging 12 badges from the G2 Reports for its groundbreaking AI-powered electronic medical record (EMR) system. This isn't just another award; it speaks volumes about their positioning across crucial areas like Physical Therapy, Medical Billing, Electronic Health Records (EHR), Patient Scheduling, and...

Continue Reading
Flanigan's Enterprises Showcases Impressive Earnings Growth

Updated Category News Views 137

Flanigan's Enterprises Reports Earnings Growth Flanigan's Enterprises, Inc., (NYSE AMERICAN: BDL) is recognized for its distinguished restaurants and retail liquor stores. The company recently showcased its financial performance for the latest 13-week and 39-week periods, and the results demonstrate substantial growth. Overview of Financial Performance For the 13 weeks...

Continue Reading
Continued Investigation into iRhythm Technologies' Management by KSF

Updated Category News Views 174

Ongoing Investigation of iRhythm Technologies New York based Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is actively investigating iRhythm Technologies, Inc. (NASDAQ: IRTC). The firm is probing potential breaches of fiduciary duty by the company’s directors and officers. The focus is on their responsibilities to shareholders in...

Continue Reading